Nextera joins the BIO International Convention

May 18, 2020 | Meet us

CEO Geir Åge Løset and CBO Ole Henrik Brekke will attend the BIO International Convention June 8^th – 12^th. Book us for a digital meeting and we will present our unique NextCore Immunology platform. Learn how this technology can leverage the target and drug discovery in complex immunological diseases. https://www.bio.org/events/bio-digital

← Previous Next →

Recent

Nextera’s unique NextCore display technology combined with state-of-the-art computational guidance efficiently generates low picomolar affinity TCR-Like antibodies
Nextera AS announces strategic collaboration with Zelluna Immunotherapy AS on development of optimized TCRs for redirected cancer immunotherapy
NextCore-generated state-of-the-art TCR-Like antibodies in celiac disease published in Science Immunology.
Nextera appoints Dr. Bent Jakobsen to the Board of Directors
Nextera partnering Multi-Functional Cell Therapies Summit, May 4-6

Sort by

Meet us
News
Publications

Nextera joins the BIO International Convention

Recent

Sort by

Nextera AS

Contact

Navigation

Recent news

Nextera’s unique NextCore display technology combined with state-of-the-art computational guidance efficiently generates low picomolar affinity TCR-Like antibodies

Nextera AS announces strategic collaboration with Zelluna Immunotherapy AS on development of optimized TCRs for redirected cancer immunotherapy